plasmid
dna
pdna
base
gene
transfer
emerg
attract
platform
target
infecti
tissu
repair
advanc
technolog
specif
intramuscular
deliveri
pdna
vivo
electropor
ep
permit
robust
express
transgen
offer
viabl
altern
platform
use
viral
product
system
level
express
gene
skelet
muscl
ideal
target
tissu
deliveri
pdna
follow
skelet
muscl
highli
vascular
possess
low
lysosom
dnase
content
highli
access
abund
throughout
vertebr
bodi
muscl
fiber
repres
singl
cell
larg
volum
syncytium
consist
multipl
nuclei
stabil
termin
differenti
state
skelet
muscl
cell
prevent
loss
pdna
cell
divis
howev
mani
hurdl
hinder
effici
deliveri
pdna
myocyt
size
neg
charg
pdna
imped
effici
passag
cell
wall
respons
sever
enabl
platform
employ
achiev
effici
gene
deliveri
muscl
impact
platform
vivo
ep
involv
transient
disrupt
cell
membran
allow
passag
pdna
cell
improv
pdna
deliveri
effici
factor
nake
pdna
deliveri
skelet
muscl
extracellular
matrix
ecm
surround
muscl
fiber
repres
barrier
act
hinder
myocyt
transfect
effici
glycosaminoglycan
gag
hyaluronan
chondroitin
sulfat
ubiquit
muscl
ecm
form
branchlik
structur
may
imped
inject
pdna
achiev
proxim
interact
previous
shown
pretreat
muscl
tissu
enzym
catalyz
hydrolysi
gag
epassist
pdna
deliveri
result
signific
enhanc
gene
express
across
chondroitin
sulfat
consist
altern
sulfatesubstitut
unit
nacetylgalactosamin
glucuron
acid
revers
disrupt
enzym
chondroitinas
hypothes
transient
enzymat
disrupt
chondroitin
sulfat
muscl
ecm
increas
access
pdna
muscl
fiber
lead
elev
transfect
rate
myocyt
increas
level
gene
express
purpos
clinic
grade
chondroitinas
abc
cho
abc
appli
epassist
pdna
deliveri
protocol
effect
local
system
gene
express
level
assess
mous
rabbit
model
importantli
advanc
protocol
describ
pdna
cho
abc
coformul
avoid
requir
pretreat
muscl
enzym
summari
clinic
relev
pdna
deliveri
protocol
describ
lead
enhanc
level
gene
express
dna
plasmid
pmer
design
previous
pmer
encod
light
heavi
chain
fulllength
antim
envelop
glycoprotein
monoclon
antibodi
light
heavi
chain
express
singl
mrna
transcript
cleav
posttransl
porcin
cleavag
site
furin
cleavag
site
rgrkrr
also
includ
ensur
complet
remov
final
vivo
produc
antibodi
pnp
encod
fulllength
nucleoprotein
np
influenza
apuerto
mer
np
transgen
clone
modifi
mammalian
express
vector
genscript
control
human
cytomegaloviru
promot
prfp
report
gene
plasmid
purchas
aldevron
fargo
nd
cho
abc
purifi
proteu
vulgari
amsbio
cambridg
hylenex
recombin
purifi
prepar
enzym
recombin
human
hyaluronidas
produc
genet
engin
chines
hamster
ovari
cell
contain
dna
plasmid
encod
solubl
fragment
human
hyaluronidas
halozym
therapeut
san
diego
ca
anim
purchas
charl
river
laboratori
wilmington
anim
hous
treatment
perform
acculab
inc
vivarium
san
diego
ca
ethic
studi
committe
protocol
number
speci
provid
parenthes
femal
balbc
mice
group
hous
four
mice
per
cage
femal
new
zealand
white
nzw
rabbit
week
old
singl
hous
femal
hartley
guinea
pig
week
old
group
hous
four
guinea
pig
per
cage
anim
husbandri
accord
guidelin
institut
care
use
committe
anim
sedat
isofluran
inhal
shave
treatment
side
prior
treatment
unless
otherwis
state
left
leg
tibiali
anterior
ta
muscl
mous
pretreat
iuml
cho
abc
min
pdna
deliveri
ep
mice
control
group
receiv
phosphatebuff
salin
pb
pretreat
pdna
administ
defin
dose
pb
intramuscularli
ep
perform
inject
ep
appli
inject
site
use
mm
electrod
devic
inovio
pharmaceut
inc
plymouth
meet
pa
two
constant
current
wave
puls
appli
muscl
site
puls
ms
long
delay
puls
set
puls
sedat
isofluran
anim
shave
treatment
site
quad
muscl
pmer
mg
per
site
ml
formul
administ
left
rabbit
quad
muscl
two
treatment
site
ep
appli
site
inject
skelet
muscl
use
devic
three
puls
appli
current
strength
puls
ms
long
delay
puls
ninetysixwel
plate
coat
goat
antihuman
immunoglobulin
g
antihigg
fc
fragment
antibodi
bethyl
laboratori
montgomeri
tx
wash
pb
tween
plate
block
fetal
bovin
serum
fb
pb
h
room
temperatur
serum
sampl
standard
dilut
ad
duplic
assay
plate
h
room
temperatur
assay
standard
purifi
monoclon
antibodi
bethyl
laboratori
dilut
began
concentr
ngml
dilut
sampl
standard
incub
h
room
temperatur
wash
secondari
antibodi
goat
antihuman
igg
kappa
light
chain
horseradish
peroxidas
hrp
bethyl
laboratori
ad
plate
incub
h
room
temperatur
plate
wash
tmb
substrat
kpl
gaithersburg
md
ad
develop
reaction
stop
tmb
stop
solut
kpl
optic
densiti
od
valu
nm
read
plate
reader
molecular
devic
san
jose
ca
ninetysixwel
plate
nuncthermo
fisher
scientif
waltham
coat
merscov
spike
protein
sinobiolog
inc
beij
pr
china
overnight
wash
pb
tween
plate
block
fbspb
h
room
temperatur
predilut
serum
sampl
ad
row
serum
serial
dilut
perform
assay
plate
nuncthermo
fisher
scientif
plate
incub
h
room
temperatur
plate
wash
secondari
antibodi
goat
antihuman
igg
kappa
light
chain
hrp
bethyl
laboratori
ad
incub
h
room
temperatur
plate
wash
tmb
substrat
kpl
ad
develop
reaction
stop
tmb
stop
solut
kpl
od
valu
nm
read
plate
reader
molecular
devic
measur
antibodi
respons
influenza
np
antigen
pate
coat
influenza
recombin
protein
sinobiolog
inc
wash
pb
tween
plate
block
h
room
temperatur
serum
sampl
dilut
pb
serial
dilut
made
serum
sampl
ad
incub
assay
plate
nuncthermo
fisher
scientif
h
room
temperatur
wash
detect
antibodi
goat
antimous
igg
hrp
antibodi
bethyl
laboratori
ad
plate
incub
h
room
temperatur
plate
wash
tmb
substrat
kpl
ad
develop
reaction
stop
tmb
stop
solut
kpl
od
valu
nm
read
plate
reader
molecular
devic
splenic
lymphocyt
prepar
perform
describ
briefli
spleen
homogen
ml
media
rpmi
medium
contain
fb
thermo
fisher
scientif
use
gentl
mac
octo
dissociat
miltenyi
biotec
auburn
ca
filtrat
step
splenocyt
resuspend
ack
lysi
buffer
remov
erythrocyt
follow
centrifug
step
cell
pellet
resuspend
media
cell
number
count
vicel
xr
cell
counter
beckman
coulter
indianapoli
measur
number
cell
secret
interferon
gamma
mous
enzymelink
immunospot
elispot
assay
kit
mabtech
inc
cincinnati
oh
use
accord
manufactur
instruct
briefli
plate
coat
immobil
cytokinespecif
monoclon
captur
antibodi
incub
overnight
plate
wash
pb
block
h
media
freshli
prepar
cell
suspens
ad
well
presenc
peptid
genscript
piscataway
nj
concanavalin
st
loui
mo
use
posit
control
media
use
neg
control
incub
h
plate
develop
accord
manufactur
instruct
spotform
cell
detect
analyz
use
immunospot
system
softwar
ctl
cleveland
oh
mice
sacrif
standard
institut
protocol
left
right
hind
limb
dissect
skin
remov
intens
plasmid
encod
red
fluoresc
protein
rfp
turborfp
ta
muscl
measur
nm
fluoresc
imag
system
proteinsimpl
san
jose
ca
quantifi
adob
photoshop
mice
sacrif
left
right
hind
limb
dissect
skelet
muscl
isol
hematoxylin
eosin
h
e
stain
h
e
stain
scan
slide
perform
reveal
bioscienc
san
diego
ca
analysi
slide
perform
use
softwar
caseview
immunofluoresc
stain
hartley
guinea
pig
sacrif
left
right
ta
muscl
dissect
fix
paraformaldehyd
incub
sucros
pb
freez
step
tissu
section
incub
cho
abc
iuml
min
chondroitin
sulfat
detect
use
mous
monoclon
antichondroitin
sulfat
antibodi
abcam
goat
antimous
igg
alexa
antibodi
abcam
cambridg
nuclei
stain
dapi
fluoromount
g
southernbiotech
birmingham
al
mice
sacrif
ta
muscl
dissect
fix
paraformaldehyd
incub
sucros
pb
freez
step
tissu
section
incub
cho
abc
iuml
hyaluronidas
iuml
h
hyaluronan
detect
use
biotinyl
habp
streptavidin
well
alexa
secondari
antibodi
abcam
nuclei
stain
dapi
fluoromount
g
southern
biotech
molecular
weight
conform
pdna
determin
agaros
gel
electrophoresi
agaros
embi
tec
san
diego
ca
tae
buffer
ladder
supercoil
pdna
kb
purchas
new
england
biolab
rowley
electrophoresi
run
v
min
analysi
perform
gene
sy
softwar
statist
analysi
perform
use
graphpad
prism
graphpad
softwar
inc
san
diego
ca
data
express
mean
error
group
compar
group
statist
test
perform
chondroitin
sulfat
ecm
structur
skelet
muscl
repres
potenti
barrier
act
effici
biodistribut
drug
tissu
aim
negat
barrier
anim
tissu
treat
chondroitin
sulfat
hydrolyz
enzym
cho
abc
specif
effect
cho
abc
muscl
chondroitin
sulfat
ecm
structur
depict
fig
loss
chondroitin
sulfat
signal
femal
hartley
guinea
pig
muscl
tissu
section
treat
cho
abc
observ
effect
cho
abc
hyaluronan
compon
ecm
limit
supplementari
fig
assess
effect
local
gene
express
target
chondroitin
sulfat
disrupt
site
pdna
deliveri
cho
abc
pb
inject
mous
ta
muscl
min
prior
deliv
pdna
encod
rfp
without
ep
mice
monitor
treatment
obviou
addit
visual
sign
imped
movement
discomfort
ep
cho
abc
group
compar
ep
pb
group
seventytwo
hour
treatment
mice
sacrif
hind
limb
dissect
skin
remov
visual
measur
rfp
intens
reveal
report
gene
express
mous
muscl
significantli
enhanc
cho
abc
ep
group
fig
c
increas
mean
fluoresc
intens
cho
abc
ep
group
arbitrari
unit
muscl
compar
pb
ep
group
arbitrari
unit
find
indic
administr
cho
abc
skelet
muscl
mice
prior
deliveri
pdna
ep
enhanc
local
gene
express
use
cho
abc
independ
ep
cho
abc
group
fail
increas
level
tissu
gene
express
significantli
background
pb
group
histolog
examin
use
h
e
stain
reveal
signific
histopatholog
differ
muscl
treat
cho
abc
pb
control
deliveri
pdna
ep
supplementari
fig
studi
proceed
assess
whether
combin
ep
cho
abc
lead
enhanc
gene
express
monitor
express
circul
protein
level
serum
mous
ta
muscl
treat
enzym
iuml
pb
min
intramuscular
deliveri
plasmid
encod
higg
molecul
target
middl
east
respiratori
syndrom
mer
cov
antigen
without
ep
day
treatment
level
higg
measur
serum
enzymelink
immunosorb
assay
elisa
fig
gene
express
analysi
perform
later
day
host
immun
respons
elicit
anim
xenogen
protein
product
higg
host
respons
associ
blunt
gene
express
later
time
point
pretreat
muscl
deliveri
site
cho
abc
cho
abc
ep
group
result
increas
higg
serum
level
ngml
compar
pb
ep
group
ngml
day
treatment
neglig
serum
level
higg
observ
group
pretreat
cho
abc
follow
pdna
deliveri
without
ep
studi
proceed
determin
optim
concentr
cho
abc
achiev
robust
gene
express
four
escal
dose
enzym
start
iuml
iuml
administ
ta
muscl
balbc
mice
min
deliveri
pmer
ep
fig
analysi
serum
higg
level
reveal
iuml
associ
highest
level
higg
detect
serum
studi
higher
dose
cho
abc
iuml
reveal
signific
differ
associ
gene
express
compar
iuml
dose
vivo
product
function
antigenbind
antibodi
confirm
mer
cov
antigenbind
elisa
fig
summari
ecm
disrupt
enzym
cho
abc
appli
epassist
intramuscular
pdna
deliveri
protocol
increas
local
system
level
encod
protein
effect
cho
abc
pdna
genedeliveri
protocol
assess
clinic
relev
surrog
anim
model
nzw
rabbit
nzw
rabbit
consid
largeanim
model
phylogenet
closer
primat
human
mice
rabbit
hindlimb
skelet
muscl
signific
larger
complex
structur
murin
muscl
importantli
size
rabbit
quad
muscl
compat
clinic
intramuscular
ep
devic
employ
protocol
incorpor
cho
abc
pretreat
muscl
studi
demonstr
enhanc
system
gene
express
epassist
pdna
deliveri
quadmuscl
site
pretreat
enzym
ngml
compar
pb
ngml
fig
aim
develop
deliveri
protocol
appropri
use
clinic
studi
investig
possibl
coformul
pdna
enzym
thu
remov
need
muscl
pretreat
step
signific
differ
serum
higg
level
measur
enzym
pretreat
coformul
group
indic
coformul
viabl
option
fig
provid
addit
time
enzym
disrupt
tissu
ecm
allow
optim
distribut
pdna
across
muscl
tissu
hypothes
extens
time
gap
inject
pdnacho
abc
coformul
tissu
initi
ep
puls
may
advantag
studi
test
whether
appli
gap
standard
gap
inject
ep
advantag
significantli
enhanc
serum
higg
level
observ
coformul
gap
group
ngml
compar
coformul
standard
group
ngml
fig
addit
studi
test
whether
combin
two
ecmdisrupt
enzym
target
differ
chondroitin
act
synergist
enhanc
vivo
gene
express
formul
hylenex
human
recombin
hyaluronidas
cho
abc
pdna
lead
increas
system
gene
express
supplementari
fig
studi
proceed
assess
whether
upon
coformul
pdna
remain
structur
stabl
enzym
retain
activ
within
scope
studi
shortterm
storag
analyz
shortterm
h
storag
coformul
influenc
two
differ
temperatur
reveal
observ
pdna
fragment
agaros
gel
electrophoresi
compar
storag
h
coformul
immedi
analysi
fig
next
studi
investig
whether
h
storag
impact
vivo
gene
express
compar
site
formul
pdna
cho
abc
mix
min
inject
h
vivo
deliveri
pdnacho
abc
coformul
store
h
ta
muscl
balbc
mice
associ
increas
gene
express
ngml
comparison
pdnapb
formul
group
ngml
fig
signific
differ
gene
express
observ
cho
abc
pretreat
site
h
ngml
h
coformul
group
ngml
strike
enhanc
local
gene
express
also
conserv
pdnacho
abc
coformul
store
h
fig
significantli
enhanc
rfp
express
level
observ
muscl
mice
administ
pdnacho
abc
coformul
arbitrari
fluoresc
intens
unit
compar
pdnapb
coformul
control
group
arbitrari
fluoresc
intens
unit
studi
assess
versatil
applic
cho
abc
genedeliveri
protocol
dna
vaccin
deliv
humor
cellular
immun
respons
elicit
singl
dose
influenza
np
antigen
pdna
pnp
vaccin
formul
without
cho
abc
deliv
intramuscularli
ep
measur
hypothes
enhanc
gene
express
associ
cho
abc
formul
would
permit
dose
spare
test
group
balbc
mice
receiv
dose
pnp
vaccin
rang
formul
cho
abc
pb
measur
humor
respons
vaccin
serum
sampl
obtain
mice
day
serum
level
np
antigenbind
antibodi
measur
elisa
day
acceler
seroconvers
observ
dose
group
mice
receiv
pnp
vaccin
formul
cho
abc
fig
clear
dose
spare
effect
detect
cho
abc
group
day
significantli
elev
antibodi
respons
detect
high
low
dose
fig
antigenspecif
cellular
respons
class
ii
class
major
histocompat
np
epitop
respect
analyz
elispot
fig
equival
cellular
immun
respons
observ
cho
abc
pb
formul
group
immun
pnp
dose
howev
lower
dose
tcell
respons
fig
tcell
respons
fig
significantli
enhanc
mice
immun
pdna
formul
cho
abc
data
suggest
employ
cho
abc
pdna
vaccin
deliveri
protocol
may
allow
vaccin
dose
spare
pdnabas
gene
deliveri
power
platform
potenti
address
unmet
medic
need
field
infecti
diseas
oncolog
gene
replac
therapi
enhanc
pdna
deliveri
protocol
increas
level
vivo
protein
product
gener
platform
delin
ep
enhanc
passag
pdna
across
cell
membran
barrier
anoth
signific
obstacl
inhibit
optim
gene
transfer
complex
branchlik
structur
ecm
ecm
may
imped
distribut
pdna
across
tissu
proxim
pdna
myocyt
neg
impact
number
cell
avail
transfect
previou
studi
ecmdisrupt
enzym
hyaluronidas
demonstr
temporari
remov
barrier
increas
pdna
diffus
tissu
increas
cell
exposur
transfect
effici
combin
epassist
enzym
cho
abc
test
aim
disrupt
ecm
barrier
bacterialderiv
cho
abc
select
sinc
enzym
clinicalgrad
product
current
investig
phase
iii
clinic
trial
treatment
radicular
leg
pain
due
lumbar
disc
herniat
nct
propos
mechan
cho
abc
catalyz
transient
hydrolysi
chondroitin
sulfat
inde
data
confirm
cho
abc
degrad
chondroitin
sulfat
skelet
muscl
ecm
disrupt
chondroitin
sulfat
muscl
may
lead
increas
tissu
permeat
access
myocyt
similar
mechan
suggest
licens
drugdeliveri
enhanc
differenti
ecm
degrad
mechan
cho
abc
hyaluronidas
hyaluronan
visual
incub
muscl
tissu
either
hyaluronidas
cho
abc
sinc
hyaluronan
significantli
affect
addit
cho
abc
supplementari
fig
data
confirm
cho
abc
specif
drive
degrad
chondroitin
sulfat
muscl
tissu
previou
studi
report
cho
abc
process
chondroitin
sulfat
dermatan
sulfat
robust
rate
clear
prefer
chondroitin
chondroitin
catalyt
effici
report
higher
compar
similarli
hyaluronidas
consid
hydrolyz
chondroitin
sulfat
howev
hyaluronidas
digest
chondroitin
sulfat
slowli
hyaluronan
prefer
substrat
hyaluronan
rather
chondroitin
repres
distinct
mechan
cho
abc
hyaluronidas
consider
studi
investig
whether
combin
use
hyaluronidas
cho
abc
led
enhanc
gene
express
howev
muscl
treatment
enzym
fail
enhanc
local
system
gene
express
use
enzym
individu
supplementari
fig
importantli
present
studi
demonstr
potenti
clinic
relev
protocol
use
cho
abc
deliveri
pdna
muscl
vivo
ep
scale
technolog
rabbit
model
use
pdna
enzym
coformul
negat
need
pretreat
step
rabbit
significantli
larger
mous
kg
vs
g
possess
greater
blood
volum
ml
vs
ml
signific
larger
muscl
phylogenet
closer
primat
addit
rabbit
favor
preclin
anim
model
ep
deliveri
protocol
sinc
size
muscl
allow
devic
use
current
appli
clinic
thu
rabbit
model
employ
develop
clinic
relev
deliveri
protocol
purpos
optim
formul
need
address
inadequaci
pretreat
protocol
administr
singl
vial
formul
would
comfort
patient
technic
simpler
clinician
timesav
parti
develop
appropri
coformul
protocol
initi
equal
system
gene
express
serum
higg
level
observ
compar
standard
pretreat
protocol
howev
enhanc
serum
higg
level
observ
time
lag
formul
inject
initi
ep
extend
current
predict
time
laps
may
allow
enzym
satur
level
ecm
disrupt
lead
increas
pdna
interact
myocyt
bolu
dispers
across
area
compat
ep
field
studi
proceed
test
stabil
coformul
pdna
suitabl
buffer
remain
stabl
longterm
storag
room
temperatur
requir
cold
chain
studi
evalu
stabil
pdna
upon
coformul
cho
abc
approach
demonstr
pdna
enzym
store
least
h
without
impact
vivo
express
gene
fig
data
provid
promis
earli
indic
concern
storag
condit
potenti
shelf
life
formul
studi
determin
longterm
storag
potenti
current
ongo
demonstr
versatil
technolog
studi
evalu
whether
cho
abc
could
employ
enhanc
immunogen
associ
dna
vaccin
protocol
result
indic
enhanc
antigen
gene
express
associ
cho
abc
deliveri
protocol
augment
immun
respons
dosedepend
manner
suggest
cho
abc
formul
permit
antigen
threshold
requir
elicit
immun
respons
achiev
lower
pdna
dose
threshold
may
achiev
without
use
cho
abc
formul
smallanim
model
mice
use
high
pdna
dose
compar
bodi
weight
mgkg
largeanim
model
human
dosetoweight
ratio
difficult
reach
use
cho
abc
formul
may
allow
higher
antigen
threshold
larger
anim
reach
activ
investig
collect
result
preclin
studi
support
continu
advanc
pdnabas
genedeliveri
protocol
employ
cho
abc
formul
cho
abc
formul
may
provid
excel
tool
develop
pdnabas
deliveri
protocol
address
wide
rang
medic
need
field
infecti
diseas
oncolog
protein
replac
therapi
